Related Experiment Video
Updated: May 29, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Varenicline as a First-Line Treatment for Individuals With Current Major Depressive Disorder Who Smoke Cigarettes
Andrea H Weinberger1, Marc L Steinberg1
1Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY (Weinberger); Department of Epidemiology and Population Health and Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY (Weinberger); Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (Steinberg).
No abstract available in PubMed .
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
CNS Depressants: Alcohol and Nicotine
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Antidepressant Drugs: Overview
Depressive Disorders: MDD and Dysthymia

